Improving Women’s Health via Innovation 

Accelerating the next generation of women’s health startups

Women’s health is one of the most underfunded and underserved areas in global healthcare, yet one of the largest economic opportunities of our time. 

At UNSW Founders, we are building Australia’s leading pipeline of women’s health startups by providing tailored, women’s health-specific support across research, clinical, and commercialisation ecosystems. 

Why Women’s Health Innovation Matters

Women’s health has long been narrowly defined as reproductive care. 
In reality, it spans the full life course and includes: 

  • Conditions that affect women exclusively 

  • Conditions that affect women differently 

  • Conditions that disproportionately impact women 

Despite this: 

  • Women spend 25% more of their lives in poor health than men 

  • Only around 5% of global healthcare R&D funding is allocated to women’s health  

  • Closing the gap could unlock $1 trillion in annual global GDP 

This is not just a health challenge. 
It is a systemic market inefficiency and a major innovation opportunity. 

How Can We Support You:

Meet Our Startup Founders Closing Women’s Health Gap

  • Amelia Bio

  • Vively

  • Arelis

  • 23 Strands

  • Neogenix BioSciences

  • Proheme Diagnostics

  • GonGlobal

What Makes UNSW Different 

UNSW is uniquely positioned to lead women’s health innovation in Australia. 

Women’s health is embedded in the UNSW Strategy 2035 and Triennium Roadmap, with a strong focus on: 

  • Research translation and impact 

  • Innovation and entrepreneurship 

  • Cross-sector collaboration  

UNSW Founders sits at the centre of this, translating research into ventures and accelerating existing women’s health ventures.

For Partners and Investors

Partner with us to access: 

  • High-quality pipeline 

  • Deep research and clinical expertise 

  • A fast-growing but undercapitalised sector